London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Short Burner
I applaud your post, so meticulous in pointing out CBX potential.
do investors know that not all cosmetic owners have a R&D section, so on that basis alone companies like Lloreal, Lancome, body shop
etc would love to use some of their research and findings.
research and development have a wide range valuation on its own merits.
Bio Synthetic cannabinoids would be game changer soon.
still firm believe that CBX would be a billion dollar company in the future.
From the prospectus...
Retail partnerships
The Company is also aware that many consumers still discover and gain trust in brands as a result of their presence in established premium large-format retailers. In the UK these include high-end department stores such as Selfridges, Harvey Nichols and Harrods, and, increasingly, premium online destination shopping sites such as Neta-porter, Cult Beauty, Space NK and Matches Fashion. The Company intends to explore retail opportunities through supply arrangements or partnerships with appropriate retail and premium online shopping businesses in due course.
Earl - do you think the R&D facility of CBX is better than that of L'Oreal and Lancome? Sadly it is this kind of garbage you are spouting that is having a negative impact on the SP and I really wish you'd stop it or at least post something factual.
...and did you see that Pureis (who are selling a synthetic CBD already) are the first company to receive validation from EFSA and FSA?
Obstando,
You slate the Earlofaim for what you describe as factually incorrect material and then compare CBX to a food supplement outfit, where the offerings contain CBD "ONLY".... No other cannabinoids at all... Hmmmmmmmmm
Pot calling the kettle black methinks.
I am pointing out that there are other biosynthetic CBD products on the market as he has stated this is some kind of USP for CBX - many of the claims that Earl is making are not true and are very misleading. I have been invested in CBD for a long while (including here) and research on products should not be taken from random posts here. I would encourage everyone to do proper research. If you are making investment decisions it is best to be well informed